The Company

ODx Innovations is developing an innovative, rapid and cost-effective point of care (POC) medical devices to help address the challenge of antimicrobial resistance.

ODx is based in Inverness. Their HQ and R&D facility operates from Solasta House, the new £4.5 million life sciences building developed by HIE on Inverness Campus with £1.5 million from the European Regional Development Fund (ERDF).

Working With ODx

“HIE and Inverness Campus beat stiff competition from other locations in the UK and overseas as a location for ODx. We are delighted with the support received from them and Scottish Enterprise.”

“We are looking forward to working with communities in Inverness, Moray and the Highlands and Islands to create jobs and help reduce the suffering caused by UTIs.”

Giles Hamilton, ODx chief executive officer


ODx on a Mission

ODx has a mission to reduce antimicrobial resistance and eliminate UTI suffering by streamlining antibiotic susceptibility testing to quickly provide prescribers with the answers they need to prescribe safely and effectively.

The days of treating Urinary Tract Infections with a best guess approach are nearly over. Antibiotic resistance is a growing global threat to health which is compounded by current prescribing practices. ODx Point of Care technology supports rapid decision making by providing answers to the question “what’s the most suitable antibiotic?”

Life Sciences in Inverness

“Inverness and the Highlands and Islands more widely, is increasingly recognised for its growing life sciences sector. ODx is at the heart of this and we are very pleased to welcome the company to the region.

“This exciting new facility fits well with the collaborative and innovative ethos of Inverness Campus. We look forward to working with the company on implementing its plans and to the benefits this will bring, notably the creation of highly-skilled jobs.”

James Cameron, HIE’s head of life sciences

Images courtesy of 360